Yellowstone Bioscience
Latest round
- Series A
Last raised
- Jun 2024
Total raised
- $21M
Investors
- 1
About Yellowstone Bioscience
Based in Oxford, UK, Yellowstone Bioscience Limited is a biotechnology firm that focuses on acute myeloid leukaemia and other HLA-II-expressing solid tumors, leveraging proprietary biobank research. Paresh Vyas (CSO) and Julian Hirst (CFO) are the co-founders of the company. The company is developing therapeutic T-cell-specific molecules designed to selectively kill cancer cells while sparing healthy cells. The firm’s approach also involves a proprietary biobank of over 10,000 samples from more than 3,000 AML patients. This biobank includes samples from high-risk AML patients cured by allogeneic stem cell transplantation. The company’s lead program focuses on AML, a disease that accounts for 62% of all leukaemia deaths. In addition, Yellowstone targets peptide-Class II antigens in other common solid organ cancers that exhibit HLA-II expression, including ovarian cancer, non-small cell lung cancer (NSCLC), colorectal cancer, prostate cancer, breast cancer, renal cancer, and melanoma.
Who invested in Yellowstone Bioscience
1 investor across 1 round
See all investors in Yellowstone Bioscience
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jun 20, 2024
Amount
$21M
Investors
Questions about Yellowstone Bioscience
Who invested in Yellowstone Bioscience?
Yellowstone Bioscience has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Yellowstone Bioscience raised?
Yellowstone Bioscience has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Yellowstone Bioscience last raise money?
Yellowstone Bioscience's most recent round on record is a Series A, in Jun 2024.
What does Yellowstone Bioscience do?
Based in Oxford, UK, Yellowstone Bioscience Limited is a biotechnology firm that focuses on acute myeloid leukaemia and other HLA-II-expressing solid tumors, leveraging proprietary biobank research.
Where is Yellowstone Bioscience headquartered?
Yellowstone Bioscience is headquartered in Oxford, UK.
Which VCs invest in companies like Yellowstone Bioscience?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Yellowstone Bioscience's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Yellowstone Bioscience? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.